Abstract
Aims
Keratan sulphate (KS) is the predominant glycosaminoglycan (GAG) present in the corneal stroma where it is thought to regulate collagen fibril diameter. In this study we investigated the distribution of KS in normal and keratoconic corneas.
Methods
Four normal, one mild, and four severe keratoconic corneas were used for the study. Distribution of keratan sulphate proteoglycans (KS-PG) was investigated using a primary monoclonal antibody (5-D-4) that recognizes disulphated disaccharides in the poly-N-acetyllactosamine repeats of KS. The immuno-reactivity of 5-D-4 was analyzed by immunohistochemistry and immuno-electron microscopy.
Results
Immuno-histochemistry showed diffuse 5-D-4 staining in keratoconic cornea compared to the punctuate staining in normal corneas. In the single cornea with mild keratoconus, immunogold microscopy revealed a very high density of KS-PG staining, especially in the posterior stroma, compared to severe keratoconic and normal cornea. The amount of KS-PG in the stroma in severe keratoconus was slightly less compared to the normal cornea. In the mild keratoconic cornea, a higher quantity of KS-PG was present around the keratocytes. In severe keratoconic corneas, a higher quantity of KS-PG was present within the keratocytes compared to normal cornea.
Conclusions
The finding of an altered expression of KS in our keratoconic corneas, in particular the strong expression of KS in keratocytes, is in keeping with reports of an altered expression of proteoglycan metabolism in keratoconus. KS-PG plays an important role in stromal collagen fibril assembly and a dysregulation of KS-PG synthesis or catabolism could explain changes in collagen fibril spacing and diameter, which we have reported elsewhere.
Similar content being viewed by others
References
Bron AJ (1988) Keratoconus. Cornea 7:163–169
Funderburgh JL, Panjwani N, Conrad GW, Baum J (1989) Altered keratan sulfate epitopes in keratoconus. Investig Ophthalmol Vis Sci 30:2278–2281
Gregory JD, Damle SP, Covington HI, Cintron C (1988) Developmental changes in proteoglycans of rabbit corneal stroma. Investig Ophthalmol Vis Sci 29:1413–1417
Hassell JR, Newsome DA, Hascall VC (1979) Characterization and biosynthesis of proteoglycans of corneal stroma from rhesus monkey. J Biol Chem 254:12346–12354
Yue BY, Sugar J, Benveniste K (1984) Heterogeneity in keratoconus possible biochemical basis. Proc Soc Exp Biol Med 175:336–341
Yue BY, Sugar J, Schrode K (1988) Histochemical studies of keratoconus. Curr Eye Res 7:81–86
Scott JE, Haigh M (1988) Identification of specific binding sites for keratan sulphate proteoglycans and chondroitin-dermatan sulphate proteoglycans on collagen fibrils in cornea by the use of cupromeronic blue in 'critical-electrolyte-concentration' techniques. Biochem J 253:607–610
Chakravarti S, Magnuson T, Lass JH, Jepsen KJ, LaMantia C, Carroll H (1998) Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J Cell Biol 141:1277–1286
Bettelheim FA, Goetz D (1976) Distribution of hexosamines in bovine cornea. Investig Ophthalmol Vis Sci 15:301–304
Hassell JR, Newsome DA, Krachmer JH, Rodrigues MM (1980) Macular corneal dystrophy: failure to synthesize a mature keratan sulfate proteoglycan. Proc Natl Acad Sci USA 77:3705–3709
Nakazawa K, Hassell JR, Hascall VC, Lohmander LS, Newsome DA, Krachmer J (1984) Defective processing of keratan sulfate in macular corneal dystrophy. J Biol Chem 259:13751–13757
Klintworth GK, Meyer R, Dennis R, Hewitt AT, Stock EL, Lenz ME, Hassell JR, Stark WJ Jr, Kuettner KE, Thonar EJ (1986) Macular corneal dystrophy. Lack of keratan sulfate in serum and cornea. Ophthalmic Paediatr Genet 7:139–143
Akama TO, Nakayama J, Nishida K, Hiraoka N, Suzuki M, McAuliffe J, Hindsgaul O, Fukuda M, Fukuda MN (2001) Human corneal GlcNac 6-O-sulfotransferase and mouse intestinal GlcNac 6-O-sulfotransferase both produce keratan sulfate. J Biol Chem 276:16271–16278
Funderburgh JL, Funderburgh ML, Rodrigues MM, Krachmer JH, Conrad GW (1990) Altered antigenicity of keratan sulfate proteoglycan in selected corneal diseases. Investig Ophthalmol Vis Sci 31:419–428
Sawaguchi S, Yue BY, Chang I, Sugar J, Robin J (1991) Proteoglycan molecules in keratoconus corneas. Investig Ophthalmol Vis Sci 32:1846–1853
Scudder P, Tang PW, Hounsell EF, Lawson AM, Mehmet H, Feizi T (1986) Isolation and characterization of sulphated oligosaccharides released from bovine corneal keratan sulphate by the action of endo-beta-galactosidase. Eur J Biochem 157:365–373
Hounsell EF, Feeney J, Scudder P, Tang PW, Feizi T (1986) 1H-NMR studies at 500 MHz of a neutral disaccharide and sulphated di-, tetra-, hexa- and larger oligosaccharides obtained by endo-beta-galactosidase treatment of keratan sulphate. Eur J Biochem 157:375–384
Mehmet H, Scudder P, Tang PW, Hounsell EF, Caterson B, Feizi T (1986) The antigenic determinants recognized by three monoclonal antibodies to keratan sulphate involve sulphated hepta- or larger oligosaccharides of the poly(N-acetyllactosamine) series. Eur J Biochem 157:385–391
Tang PW, Scudder P, Mehmet H, Hounsell EF, Feizi T (1986) Sulphate groups are involved in the antigenicity of keratan sulphate and mask i antigen expression on their poly-N-acetyllactosamine backbones. An immunochemical and chromatographic study of keratan sulphate oligosaccharides after desulphation or nitrosation. Eur J Biochem 160:537–545
Akhtar S, Bron AJ, Hawksworth NR, Bonshek RE, Meek KM (2001) Ultrastructural morphology and expression of proteoglycans, βig-h3, tenascin-C, fibrillin-1, and fibronectin in bullous keratopathy. Br J Ophthalmol 85:720–731
Kao WWY, Liu CY (2003) Role of lumican and keratocan on corneal transparency. Glycoconj J 19:275–285
Sherwin T, Brookes NH, Loh IP, Poole CA, Clover GM (2002) Cellular incursion into Bowman's membrane in the peripheral cone of the keratoconus cornea. Exp Eye Res 74:473–482
Whitelock RB, Fukuchi T, Zhou L, Twining SS, Sugar J, Feder RS, Yue BY (1997) Cathepsin G, acid phosphatase, and alpha 1-proteinase inhibitor messenger RNA levels in keratoconus corneas. Investig Ophthalmol Vis Sci 38:529–534
Zhou L, Sawaguchi S, Twining SS, Sugar J, Feder RS, Yue BY (1998) Expression of degradative enzymes and protease inhibitors in corneas with keratoconus. Investig Ophthalmol Vis Sci 39:1117–11124
Kielty CM, Lees M, Shuttleworth CA, Woolley D (1993) Catabolism of intact type VI collagen microfibrils: susceptibility to degradation by serine proteinases. Biochem Biophys Res Commun 191:1230–1236
Zimmermann DR, Fischer RW, Winterhalter KH, Witmer R, Vaughan L (1988) Comparative studies of collagens in normal and keratoconus corneas. Exp Eye Res 46:431–442
Reale E, Groos S, Luciano L, Eckardt C, Eckardt U (2001) In the mammalian eye type VI collagen tetramers form three morphologically different aggregates. Matrix Biol 20:37–51
Kenney MC, Chwa M, Atilano SR, Tran A, Carballo M, Saghizadeh M, Vasiliou V, Adachi W, Brown DJ (2005) Increased levels of catalase and cathepsin V/L2 but decreased TIMP-1 in keratoconus corneas: evidence that oxidative stress plays a role in this disorder. Investig Ophthalmol Vis Sci 46:823–832
Bureau J, Fabre EJ, Hecquet C, Pouliquen Y, Lorans G (1993) Modification of prostaglandin E2 and collagen synthesis in keratoconus fibroblasts, associated with an increase of interleukin 1 alpha receptor number. C R Acad Sci III 316:425–430
Akhtar S, Bron AJ, Salvi SM, Hawksworth NR, Tuft SJ, Meek KM (2008) Collagen fibrils and proteoglycans in keratoconus - a quantitative ultra-structural analysis. Acta Ophthalmol 86:764–772
Rada JA, Cornuet PK, Hassell JR (1993) Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins. Exp Eye Res 56:635–648
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Akhtar, S., Bron, A.J., Hayes, A.J. et al. Role of keratan sulphate (sulphated poly -N-acetyllactosamine repeats) in keratoconic cornea, histochemical, and ultrastructural analysis. Graefes Arch Clin Exp Ophthalmol 249, 413–420 (2011). https://doi.org/10.1007/s00417-010-1512-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-010-1512-9